Sulfasalazine NDC 0093-3234

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-3234Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-3234Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0093-3234-01	00093323401	100 TABLET in 1 BOTTLE, PLASTIC (0093-3234-01)Marketed from Dec 15, 2022
0093-3234-05	00093323405	500 TABLET in 1 BOTTLE, PLASTIC (0093-3234-05)Marketed from Feb 27, 2023
0093-3234-10	00093323410	1000 TABLET in 1 BOTTLE, PLASTIC (0093-3234-10)Marketed from Dec 15, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfasalazine
Generic name (nonproprietary): sulfasalazine
Active ingredients: Sulfasalazine — 500 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 085828
Marketing start: Dec 15, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Aminosalicylic Acids (Chemical structure)
Identifiers: Product ID 0093-3234_6bb77fd9-0f19-4f91-8eb9-33d9c6b5c471SPL ID 6bb77fd9-0f19-4f91-8eb9-33d9c6b5c471SPL set ID 3c59593b-e1a5-47cb-a82b-3e5e49205344RxCUI 198232UNII 3XC8GUZ6CBUPC 0300933234016
Pharmacologic class: Aminosalicylate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093323401 followed by a unit qualifier and the quantity

Package 00093-3234-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 22, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 085828

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 085828
Product	Strength	Form · route	Labeler	Product NDC
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Bryant Ranch Prepack	63629-9715